 |
| Download
the Brochure
According
to a spokesperson, the genetic studies on fibromyalgia are well underway – with
the assistance of the University of California, UCLA, and University of
Illinois at Chicago. There has been a strong response from the fibromyalgia
community in participating in these efforts. As you may recall from my blog, The
FM/a® Blood Test and Campaign 250: Participation in Fibromyalgia Exome and
Treatment Study, EpicGenetics is allowing up to 250,000 participants in
this research effort and the opportunity to enroll will likely end later in
2018 to allow for the analysis of the genomic surveys and results announcement.
So, if you haven’t already, I encourage you to look into getting the FM/a test now, so you can be part
of this important research. Participation in the research first requires a
positive FM/a® Test, and if you do receive a positive test result, you will
receive a direct communication from EpicGenetics inviting you to participate.
Researcher
investigating possible fibromyalgia vaccine
Additionally,
the clinical trial set to take place at Massachusetts General Hospital to
evaluate the BCG vaccine as a direct, effective treatment continues to progress
toward enrollment and trial initiation. Plans are to initiate the trials during
the first half of this year. You can read more about this breaking news in my
blog, EpicGenetics
Announces Major Clinical Study to Locate Genetic Markers Unique to People with
Fibromyalgia and Explore New Treatment Approaches.
Additional:
Thank
you for taking this journey with me.
|
In healing,
Celeste Cooper, RN / Author, Freelancer, Advocate
Think adversity?-See opportunity!
Posts
No comments:
Post a Comment